ZA961008B - Compounds with growth hormone releasing properties - Google Patents

Compounds with growth hormone releasing properties

Info

Publication number
ZA961008B
ZA961008B ZA961008A ZA961008A ZA961008B ZA 961008 B ZA961008 B ZA 961008B ZA 961008 A ZA961008 A ZA 961008A ZA 961008 A ZA961008 A ZA 961008A ZA 961008 B ZA961008 B ZA 961008B
Authority
ZA
South Africa
Prior art keywords
compounds
growth hormone
hormone releasing
releasing properties
properties
Prior art date
Application number
ZA961008A
Inventor
Michael Ankersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA961008B publication Critical patent/ZA961008B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA961008A 1995-02-09 1996-02-08 Compounds with growth hormone releasing properties ZA961008B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK14795 1995-02-09

Publications (1)

Publication Number Publication Date
ZA961008B true ZA961008B (en) 1996-08-29

Family

ID=8090300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961008A ZA961008B (en) 1995-02-09 1996-02-08 Compounds with growth hormone releasing properties

Country Status (4)

Country Link
AU (1) AU4534696A (en)
IL (1) IL117076A0 (en)
WO (1) WO1996024587A1 (en)
ZA (1) ZA961008B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CA2362290A1 (en) 1999-02-18 2000-08-24 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
ATE446758T1 (en) 2000-05-31 2009-11-15 Pfizer Prod Inc USE OF GROWTH HORMONE SECRETAGOGENES TO PROMOTE DIGESTIVE MOTILITY
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
CN103313968A (en) 2010-11-15 2013-09-18 Abbvie公司 Nampt and rock inhibitors
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Also Published As

Publication number Publication date
AU4534696A (en) 1996-08-27
IL117076A0 (en) 1996-06-18
WO1996024587A1 (en) 1996-08-15

Similar Documents

Publication Publication Date Title
HUP9802580A3 (en) Compounds with growth hormone releasing properties
IL122371A0 (en) Compounds with growth hormone releasing properties
NO973446L (en) Compounds with growth hormone releasing properties
EP0741578A4 (en) Human growth hormone
ZA985278B (en) Compounds with growth hormone releasing properties
AU2382097A (en) Compounds with growth hormone releasing properties
ZA961007B (en) Compounds with growth hormone releasing properties
ZA961008B (en) Compounds with growth hormone releasing properties
GB9415958D0 (en) Anglers aid
ZA965279B (en) Compounds with growth hormone releasing properties
ZA9610775B (en) Compounds with growth hormone releasing properties
ZA96544B (en) Compounds with growth hormone releasing properties
ZA9410262B (en) Compounds with growth hormone releasing properties
ZA9410261B (en) Compounds with growth hormone releasing properties
ZA973483B (en) Compounds with growth hormone releasing properties.
GB9225928D0 (en) Growth factor
GB9424232D0 (en) Growth factor expression
EP0891372A4 (en) Growth factor htter36
KR0108925Y1 (en) Sinker
KR0110391Y1 (en) Supprort for fishing-rods
HU867U (en) Tackle
ZA99238B (en) Compounds with growth hormone releasing properties.
ZA200005820B (en) Compounds with growth hormone releasing properties.
PL102999U1 (en) Small umbrella for anglers
GB9514254D0 (en) Float-ledger fishing